amyotrophic-lateral-sclerosis

Documents about amyotrophic-lateral-sclerosis

• Dazucorilant in Patients With Amyotrophic Lateral Sclerosis#1451314ClinicalTrials.gov
• Amyotrophic Lateral Sclerosis: A Multicenter Retrospective Observational Registry#873107ClinicalTrials.gov
• Amyotrophic Lateral Sclerosis Registry#846156ClinicalTrials.gov
• Amyotrophic Lateral Sclerosis Registry in Thailand#901687ClinicalTrials.gov
• A Study of VRG50635 in Participants With Amyotrophic Lateral Sclerosis (ALS)#995342ClinicalTrials.gov
• Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis#912966ClinicalTrials.gov
• Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis#1466221ClinicalTrials.gov
• Systems Biology of Amyotrophic Lateral Sclerosis (ALS)#1162973ClinicalTrials.gov
• Triumeq in Amyotrophic Lateral Sclerosis#1280437ClinicalTrials.gov
• In-situ Cytokines Expression in the CNS in Amyotrophic Lateral Sclerosis (ALS)#890185ClinicalTrials.gov
• Tongue-strengthening Exercises in People With ALS.#867877ClinicalTrials.gov
• A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.#906365ClinicalTrials.gov
• Amyotrophic Lateral Sclerosis Non-invasive Ventilation Exchange#1420398ClinicalTrials.gov
• Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)#1486864ClinicalTrials.gov
• Therapeutic Imaging Biomarkers for Amyotrophic Lateral Sclerosis#889642ClinicalTrials.gov
• Enoxacin for Amyotrophic Lateral Sclerosis (ALS)#993932ClinicalTrials.gov
• A Study to Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participants With Amyotrophic Lateral Sclerosis (ALS)#846966ClinicalTrials.gov
• Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS)#801481ClinicalTrials.gov
• Polysomnography-directed Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS)#915639ClinicalTrials.gov
• Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)#1030842ClinicalTrials.gov
• Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis#831814ClinicalTrials.gov
• Study to Evaluate DNL747 in Subjects With Amyotrophic Lateral Sclerosis#848608ClinicalTrials.gov
• Multidisciplinary Follow-up of Patients With Amyotrophic Lateral Sclerosis#1477261ClinicalTrials.gov
• Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis#1150384ClinicalTrials.gov
• A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)#1464141ClinicalTrials.gov
• Effects of L-Carnitine in Amyotrophic Lateral Sclerosis Patients With CHCHD10 Mutations#1478186ClinicalTrials.gov
• A Long-term Extension Study of TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis(ALS)#1127859ClinicalTrials.gov
• Mesenchymal Stem Cell Injection in Amyotrophic Lateral Sclerosis#837617ClinicalTrials.gov
• Contralateral R1 in Amyotrophic Lateral Sclerosis#875361ClinicalTrials.gov
• Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)#885792ClinicalTrials.gov
• Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis#1213978ClinicalTrials.gov
• Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)#1228514ClinicalTrials.gov
• Tongue Strength in Amyotrophic Lateral Sclerosis (ALS)#1294681ClinicalTrials.gov
• COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry#1440199ClinicalTrials.gov
• Masitinib in Combination With Riluzole for the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)#896124ClinicalTrials.gov
• Sinemet for Spasticity and Function in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis#1377080ClinicalTrials.gov
• Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment#830814ClinicalTrials.gov
• Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)#862347ClinicalTrials.gov
• A Physiotherapy Intervention Study in Patients With Amyotrophic Lateral Sclerosis (ALS)#887706ClinicalTrials.gov
• Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS)#894523ClinicalTrials.gov
• Evaluate PU-AD in Subjects With Amyotrophic Lateral Sclerosis#1073525ClinicalTrials.gov
• Modeling Amyotrophic Lateral Sclerosis With Fibroblasts#1150009ClinicalTrials.gov
• Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS)#1150489ClinicalTrials.gov
• Fatigue in Patients With Amyotrophic Lateral Sclerosis#1229848ClinicalTrials.gov
• Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS)#1283022ClinicalTrials.gov
• Biomarker-driven Phenotypic Dissection of Amyotrophic Lateral Sclerosis#1294665ClinicalTrials.gov
• PRE-Symptomatic Studies in Amyotrophic Lateral Sclerosis#1371070ClinicalTrials.gov
• Food Supplement for the Treatment of Patients With Amyotrophic Lateral Sclerosis#1385333ClinicalTrials.gov
• Registration Study of Amyotrophic Lateral Sclerosis (ALS) in Mainland China#1421605ClinicalTrials.gov
• Non-invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Using the iVAPS Mode#1163825ClinicalTrials.gov